Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Opat

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Vnitrni Lekarstvi|September 1, 1991
[Biological aspects of paraneoplastic syndromes]P Opat
Journal of Personalized Medicine|January 21, 2022
Targeted Therapy in Leukaemia, Lymphoma and MyelomaStephen Samuel Opat
Future Oncology (London, England)|October 16, 2020
An update of venetoclax and obinutuzumab in chronic lymphocytic leukemiaRoss Salvaris, Stephen Opat
Future Oncology (London, England)|September 11, 2025
Zanubrutinib in the treatment of Waldenström MacroglobulinemiaElizabeth Goodall, Stephen Opat
British Journal of Haematology|May 30, 2024
Large cell lymphoma through a liquid lensJake Shortt, Stephen Opat
Leukemia & Lymphoma|January 29, 2025
Indolent lymphoma: addressing the needs of survivorsPasquale L Fedele, Stephen Opat
Neoplasma|January 1, 1979
BCG vaccination in Hodgkin's lymphogranulomaV Kolár, P Opat, N Hrdlicková
Neoplasma|January 1, 1989
High dose alpha-2-recombinant interferon in the treatment of malignant lymphoproliferative diseases. A pilot studyP Opat, J Drbal, R Vyzula
Clinical and Experimental Pharmacology & Physiology|January 1, 1978
Effects of monosodium glutamate-induced obesity in mice on carbohydrate metabolism in insulin secretionD P Cameron, L Cutbush, F Opat
European Journal of Cancer & Clinical Oncology|August 1, 1988
Alteration of beta-2-microglobulin level in malignant lymphoproliferative diseases after a high dose of alpha-2-recombinant interferonP Opat, J Drbal, Z Tauer, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Vnitrni Lekarstvi|September 1, 1991
[Biological aspects of paraneoplastic syndromes]P Opat
Journal of Personalized Medicine|January 21, 2022
Targeted Therapy in Leukaemia, Lymphoma and MyelomaStephen Samuel Opat
Future Oncology (London, England)|October 16, 2020
An update of venetoclax and obinutuzumab in chronic lymphocytic leukemiaRoss Salvaris, Stephen Opat
Future Oncology (London, England)|September 11, 2025
Zanubrutinib in the treatment of Waldenström MacroglobulinemiaElizabeth Goodall, Stephen Opat
British Journal of Haematology|May 30, 2024
Large cell lymphoma through a liquid lensJake Shortt, Stephen Opat
Leukemia & Lymphoma|January 29, 2025
Indolent lymphoma: addressing the needs of survivorsPasquale L Fedele, Stephen Opat
Neoplasma|January 1, 1979
BCG vaccination in Hodgkin's lymphogranulomaV Kolár, P Opat, N Hrdlicková
Neoplasma|January 1, 1989
High dose alpha-2-recombinant interferon in the treatment of malignant lymphoproliferative diseases. A pilot studyP Opat, J Drbal, R Vyzula
Clinical and Experimental Pharmacology & Physiology|January 1, 1978
Effects of monosodium glutamate-induced obesity in mice on carbohydrate metabolism in insulin secretionD P Cameron, L Cutbush, F Opat
European Journal of Cancer & Clinical Oncology|August 1, 1988
Alteration of beta-2-microglobulin level in malignant lymphoproliferative diseases after a high dose of alpha-2-recombinant interferonP Opat, J Drbal, Z Tauer, et al.
Pageof 14